USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
INTEGRAL MOLECULAR
Address:
3711 MARKET ST
Suite 900
PHILADELPHIA, PA
EIN:
233091965
DUNS:
034055645
Number of Employees:
25
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $4,706,165.00 17
SBIR Phase II $6,464,872.00 5
STTR Phase I $1,306,708.00 3
STTR Phase II $3,668,057.00 2

Award List:

HIV ENVELOPE CELL-ARRAYS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$101,115.00
Agency:
HHS
Principal Investigator:
Abstract:
ViraCore is a biotechnology company developing a drug discovery tool, the cell-array, that enables scientists in academia and industry to determine the function of thousands of protein variants simultaneously without the need for prior sequencing or individual site-directed mutagenesis. We propose… More

VIRACORE PSEUDOTYPE PRODUCTION OPTIMIZATION

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$94,374.00
Agency:
HHS
Principal Investigator:
Abstract:
ViraCore's technology uses a biosensor-based technique that is capable of identifying, measuring, and characterizing drug interactions with membrane-bound receptors, a protein family targeted by 50 percent of the world's drugs. Membrane receptors such as G-protein coupled receptors (GPCRs) are… More

VIRACORE BIOSENSOR OPTIMIZATION

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$94,374.00
Agency:
HHS
Principal Investigator:
Abstract:
ViraCore's technology uses a biosensor-based technique that is capable of identifying, measuring, and characterizing drug interactions with membrane-bound receptors, a protein family targeted by 50 percent of the world's drugs. Membrane receptors such as G-protein coupled receptors (GPCRs) are… More

ANTIBODIES TO COMPLEX RECEPTORS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$200,090.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): ViraCore is a biotechnology company that is creating a drug discovery tool that is capable of presenting complex receptors in a nanometer-sized particle format. Specific ally, ViraCore is using "lipoparticles", nanometer -sized particles surrounded by a lipid… More

Biosensor Optimization for Membrane Protein Studies

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$1,193,719.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Optical biosensors are a class of instruments that can detect intramolecular interactions in real-time, without labels, and with high sensitivity. Their use has grown at a 25-40 percent annual rate since the early 1990's, and biosensors have been integrated into… More

Pseudotype Production Optimization

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$862,420.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): ViraCore is a tool-based biotechnology company that is creating a drug discovery platform for use by the pharmaceutical and biotechnology industries. ViraCore is developing "lipoparticles", nanometer-sized particles surrounded by a lipid bilayer and embedded… More

A cell-free system for assaying ion channel function

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$199,200.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Ion channels function as signaling intermediaries that are involved in nerve signal propagation, muscle contraction, cardiopulmonary regulation, and cell metabolism. Their importance is underscored by the existence of dozens of ion channel-specific drugs that… More

A cell-free system for assaying ion channel function

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$1,144,842.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Ion channels function as cell-signaling effectors for a diverse range of physiological activities, including nerve signal propagation, muscle contraction, cardiopulmonary regulation, and cell metabolism. Their impact on human health is underscored by the… More

Detection of GPCR Function in Cell-free Nanoscale System

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$289,264.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The G protein-coupled receptor (GPCR) CXCR4 is a determinant of the pathogenesis of HIV-1 infection and breast cancer, but efforts to develop drugs that modify its function have been unsuccessful. Traditional assays that screen GPCR function mostly use live… More

Cell-free Biosensor for the Detection of Pathogens

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Biosensors capable of detecting infectious agents, and/or of detecting a serological reaction in people potentially exposed to dangerous pathogens, are fundamental to rapid biodefense screening and response processes. Biosensors based on the signaling properties… More

Novel Multifunctional Probes

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$100,366.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Classical visual probes operate by binding to and illuminating a target molecule of interest. However, most probes are limited in response to a single event, binding to a single target, or reporting a single phenomenon. This is a significant limitation for… More

Membrane Protein Production using Retroviral Vehicles

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$165,155.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Despite their importance, proteins that span the membrane multiple times present a unique set of challenges for structural analyses such as x-ray crystallography. Large portions of these proteins are hydrophobic, the proteins are topologically complex, and… More

SMART Arrays for Pathogen Detection

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$180,734.00
Agency:
HHS
Principal Investigator:
Tiffani Greene
Abstract:
DESCRIPTION (provided by applicant): Sensors for rapid and sensitive detection of human pathogens are fundamental to biodefense screening and emergency response procedures. The availability of sensors that can additionally detect antibodies against such pathogens would indicate prior exposure, as… More

Modeling the Structure-Activity of Chemokine Receptors

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$222,303.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Understanding the precise molecular interactions between drugs and their targets, their structure-activity relationship (SAR), is a highly desirable goal during drug development. Elucidation of SAR for G protein-coupled receptors (GPCRs) is a complicated task… More

Dengue Reporter Virus Neutralization Assay for Clinical Studies

Award Year / Program / Phase:
2007 / STTR / Phase II
Award Amount:
$2,649,021.00
Agency:
HHS
Principal Investigator:
Research Institution:
REGENTS OF THE UNIVERSITY OF CALIFORNIA
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Dengue virus (DENV) is the most significant cause of arthropod-borne viral disease in humans, resulting in an estimated 50 million cases of dengue fever and over 450,000 cases of life-threatening dengue hemorrhagic feve r/dengue shock syndrome (DHF/DSS) each… More

A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRs

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$2,070,966.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Understanding the precise molecular interactions between drugs and their targets, their structure-activity relationship (SAR), is a highly desirable goal during drug development. GPCRs are the single largest family of d rug targets in the pharmaceutical industry,… More

Cell-free Detection of GPCR Signaling in a Nanoscale System

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$1,192,925.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): G protein-coupled receptors (GPCRs) are one of the most important families of pharmaceutical targets. However, some of the most desirable types of GPCR drugs have also been some of the most difficult to discover. GPCRs are integral membrane proteins that are… More

Identification of Novel Influenza Inhibitors

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$599,243.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Influenza virus is a Category C biodefense pathogen of global public health concern because it causes 3-5 million cases of severe illness every year, and because of the potential for the emergence of new, highly pathoge nic strains that could cause pandemic… More

Development of taste receptor ligands using structure-activity studies

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$696,243.00
Agency:
HHS
Principal Investigator:
Joseph B. Rucker
Abstract:
DESCRIPTION (provided by applicant): As the primary mechanism by which animals detect nutrient-rich foods and discriminate against toxins, the sense of taste has a significant impact on health and behavior. Bitter tastes are perceived with high sensitivity and broad specificity, and can evoke… More

High-throughput Epitope Mapping of Anti-Viral Antibodies

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$242,376.00
Agency:
HHS
Principal Investigator:
Benjamin J. Doranz – 215-966-6018
Abstract:
DESCRIPTION (provided by applicant): The identification of highly potent and broadly neutralizing antibodies isolated from HIV-1- infected donors suggests that when presented with a suitable antigenic structure, the human immune system can produce protective antibodies that HIV-1 is unable to evade.… More

Isolation of Monoclonal Antibodies against Membrane Proteins

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$660,813.00
Agency:
HHS
Principal Investigator:
Joseph B. Rucker – 215-966-6069
Abstract:
DESCRIPTION (provided by applicant): Because of their importance in cell signaling and human disease, integral membrane proteins such as G protein-coupled receptors (GPCRs) and ion channels comprise over 40% of existing drug targets. Monoclonal antibodies(MAbs) that recognize conformation-dependent… More

Engineering Stable, Soluble, and Trimeric HIV gp140 by Paired Cys Scanning

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$546,301.00
Agency:
HHS
Principal Investigator:
Benjamin J. Doranz – 215-966-6018
Abstract:
DESCRIPTION (provided by applicant): When presented with a suitable antigenic Envelope (Env) structure, the human immune system can produce protective antibodies that HIV is unable to evade. Many of the most potently neutralizing HIV antibodies identifiedto date preferentially bind the trimeric… More

Phage Display Isolation of Antibodies against Antigenically Conserved Membrane Pr

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$214,214.00
Agency:
HHS
Principal Investigator:
Benjamin J. Doranz – 215-966-6018
Abstract:
DESCRIPTION (provided by applicant): We propose to use a novel technology, the Lipoparticle, to capture and concentrate structurally intact membrane proteins in a format amenable to phage panning for MAb isolation. The use of Lipoparticles to pan phage display libraries represents a valuable… More